ADAKVEO (Crizanlizumab)
ADAKVEO is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease. ADAKVEO is a selectin…
Novartis Pharmaceuticals Corporation Products: Prescription Medications Section
Afinitor (Everolimus)
AFINITOR is a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive. HER2-negative breast cancer in combination with exemestane…
ARGATROBAN
Argatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) (1.1) As an…
Arranon (Nelarabine)
ARRANON is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose…
ARZERRA (Ofatumumab)
Chronic Lymphocytic Leukemia (CLL). ARZERRA (ofatumumab) is indicated: in combination with chlorambucil, for the treatment of previously untreated patients with CLL for whom…